cal Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer
10.4166/kjg.2020.75.5.264
- Author:
Chan Hyuk PARK
1
;
Dong-Hoon YANG
;
Jong Wook KIM
;
Jie-Hyun KIM
;
Ji Hyun KIM
;
Yang Won MIN
;
Si Hyung LEE
;
Jung Ho BAE
;
Hyunsoo CHUNG
;
Kee Don CHOI
;
Jun Chul PARK
;
Hyuk LEE
;
Min-Seob KWAK
;
Bun KIM
;
Hyun Jung LEE
;
Hye Seung LEE
;
Miyoung CHOI
;
Dong-Ah PARK
;
Jong Yeul LEE
;
Jeong-Sik BYEON
;
Chan Guk PARK
;
Joo Young CHO
;
Soo Teik LEE
;
Hoon Jai CHUN
Author Information
1. Department of Gastroenterology, Hanyang University Guri Hospital, Guri, Korea
- Publication Type:REVIEW ARTICLE
- From:The Korean Journal of Gastroenterology
2020;75(5):264-291
- CountryRepublic of Korea
-
Abstract:
Although surgery was the standard treatment for early gastrointestinal cancers, endoscopic resection is now a standard treatment for early gastrointestinal cancers without regional lymph node metastasis. High-definition white light endoscopy, chromoendoscopy, and image-enhanced endoscopy such as narrow band imaging are performed to assess the edge and depth of early gastrointestinal cancers for delineation of resection boundaries and prediction of the possibility of lymph node metastasis before the decision of endoscopic resection. Endoscopic mucosal resection and/or endoscopic submucosal dissection can be performed to remove early gastrointestinal cancers completely by en bloc fashion. Histopathological evaluation should be carefully made to investigate the presence of risk factors for lymph node metastasis such as depth of cancer invasion and lymphovascular invasion. Additional treatment such as radical surgery with regional lymphadenectomy should be considered if the endoscopically resected specimen shows risk factors for lymph node metastasis. This is the first Korean clinical practice guideline for endoscopic resection of early gastrointestinal cancer. This guideline was developed by using mainly de novo methods and encompasses endoscopic management of superficial esophageal squamous cell carcinoma, early gastric cancer, and early colorectal cancer. This guideline will be revised as new data on early gastrointestinal cancer are collected.
